Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
about
Validation and Comparison of the Therapeutic Efficacy of Boron Neutron Capture Therapy Mediated By Boron-Rich Liposomes in Multiple Murine Tumor Models.Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancerThe Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapyComparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study.Boron Neutron Capture Therapy - A Literature Review.Effect of oxygen pressure during incubation with a (10)B-carrier on (10)B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of (10)B-carriers.Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET.Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy.Whole-body dose evaluation with an adaptive treatment planning system for boron neutron capture therapy.Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection.Non-invasive estimation of 10 B-4-borono-L-phenylalanine-derived boron concentration in tumors by PET using 4-borono-2-18 F-fluoro-phenylalanine.
P2860
Q33875030-305CFB9C-92FF-466B-BDC8-65A1DD523320Q33881254-F27F3A2B-A38D-416C-8C89-AE1C1A028A12Q35760848-45C22F87-4AD3-465C-9A22-BEFCEC2CB4F4Q36184779-4850CBCF-89D0-49D7-A591-CC574ABF4648Q37348292-F935B3D3-94EE-4F53-8073-8E0AECEEF13EQ37630245-6ABA7A09-F33E-4BAB-B94F-975E2375AD50Q38793345-67001E62-A79B-4A3B-84E1-5C2EA6BA8369Q38825221-DBF51666-3A07-4FF4-B907-E261E070B45BQ39003781-1B21E6B8-FA6E-4F0E-B326-E7312DE83558Q42210286-7A9A4FC9-9408-4E0B-99E9-E9DF6ADA212FQ47184614-001BB2CD-978D-4E9F-9B90-1C91F26D00B1Q48408462-078BEE3A-25FC-449F-8E1B-A4601075AFD0Q49255187-08AB7BA4-F098-4AEE-A2B3-1AE24296B268Q52729361-43321D70-F11F-4A69-9CA2-394328ED2293
P2860
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@en
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@nl
type
label
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@en
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@nl
prefLabel
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@en
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@nl
P2093
P2860
P356
P1476
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
@en
P2093
Akira Maruhashi
Ituro Kato
Junichi Hiratsuka
Kenichi Yoshimura
Masanori Fukushima
Minoru Suzuki
Miyuki Niimi
Shin-Ichi Haginomori
Shin-Ichiro Masunaga
P2860
P304
P356
10.1093/JRR/RRT098
P577
2013-08-16T00:00:00Z